Aptevo Therapeutics Proclaims $3.0 Million Providing Priced At-the-Market Beneath Nasdaq Guidelines By Investing.com
SEATTLE, WA / ACCESSWIRE / September 16, 2024 / Aptevo Therapeutics Inc…
Paylocity publicizes CTO departure, seek for successor By Investing.com
Paylocity (NASDAQ:) Holding Corp (NASDAQ:PCTY), a supplier of cloud-based payroll and human…
Celularity broadcasts govt departure By Investing.com
Celularity Inc. (NASDAQ:CELU), a biotechnology firm specializing in pharmaceutical preparations, introduced the…
AFC Gamma Publicizes First Publish-Spin Dividend for the Third Quarter 2024 By Investing.com
WEST PALM BEACH, Fla., Sept. 13, 2024 (GLOBE NEWSWIRE) -- AFC Gamma,…
Flooring & Decor Pronounces Grand Opening of Bailey’s Crossroads, Virginia Retailer By Investing.com
- Main high-growth retailer specializing in hard-surface flooring affords owners and professionals…
Owlet Declares Pricing of Public Providing and Complete Debt Refinancing for Complete Gross Proceeds of as much as $46.6 Million By Investing.com
The Firm anticipates receiving $11.6 million in proceeds from the underwritten public…
Affinia Therapeutics Publicizes the Appointment of Rami Daoud as Chief Business and Monetary Officer By Investing.com
Trade veteran Daoud brings greater than 25 years' expertise in enterprise improvement…
AmpliTech Group Declares Pricing of $1.0 Million Registered Direct Providing, Priced At-The-Market By Investing.com
HAUPPAUGE, N.Y., Sept. 09, 2024 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq:…
LifeWallet Launches Initiative to Safe New Agreements with Well being Plans, Suppliers, Insurers and Attorneys, Continues Price Slicing Efforts, and Pronounces it Secured a Waiver of Acceleration Based mostly on By Investing.com
CORAL GABLES, Fla., Sept. 08, 2024 (GLOBE NEWSWIRE) -- MSP Restoration, Inc.…
Longboard Prescription drugs Broadcasts Optimistic Interim Evaluation Outcomes from the Open-Label Extension (OLE) of the Part 1b/2a PACIFIC Examine Evaluating Bexicaserin in Members with Developmental and By Investing.com
Bexicaserin achieved an general median seizure discount of 57.7% in countable motor…